Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hexachlorophene 1g | Login | Hexachlorophene 1g | ||||||||||||||||
|
||||||||||||||||||
| CMPD-1 5mg | Login | CMPD-1 5mg | ||||||||||||||||
|
||||||||||||||||||
| CMPD-1 10mg | Login | CMPD-1 10mg | ||||||||||||||||
|
||||||||||||||||||
| CMPD-1 50mg | Login | CMPD-1 50mg | ||||||||||||||||
|
||||||||||||||||||
| HI TOPK 032 5mg | Login | HI TOPK 032 5mg | ||||||||||||||||
|
||||||||||||||||||
| HI TOPK 032 10mg | Login | HI TOPK 032 10mg | ||||||||||||||||
|
||||||||||||||||||
| HI TOPK 032 50mg | Login | HI TOPK 032 50mg | ||||||||||||||||
|
||||||||||||||||||
| c-JUN peptide 1mg | Login | c-JUN peptide 1mg | ||||||||||||||||
|
||||||||||||||||||
| c-JUN peptide 2mg | Login | c-JUN peptide 2mg | ||||||||||||||||
|
||||||||||||||||||
| Macbecin I 1mg | Login | Macbecin I 1mg | ||||||||||||||||
|
||||||||||||||||||
| Chlorothricin 1mg | Login | Chlorothricin 1mg | ||||||||||||||||
|
||||||||||||||||||
| PROTAC FAK degrader 1 1mg | Login | PROTAC FAK degrader 1 1mg | ||||||||||||||||
|
||||||||||||||||||
| PROTAC FAK degrader 1 5mg | Login | PROTAC FAK degrader 1 5mg | ||||||||||||||||
|
||||||||||||||||||
| PROTAC FAK degrader 1 10mg | Login | PROTAC FAK degrader 1 10mg | ||||||||||||||||
|
||||||||||||||||||
| PROTAC FAK degrader 1 50mg | Login | PROTAC FAK degrader 1 50mg | ||||||||||||||||
|
||||||||||||||||||
| Ikarugamycin 1mg | Login | Ikarugamycin 1mg | ||||||||||||||||
|
||||||||||||||||||
| cIAP1 Ligand-Linker Conjugates 1 1mg | Login | cIAP1 Ligand-Linker Conjugates 1 1mg | ||||||||||||||||
|
||||||||||||||||||
| cIAP1 Ligand-Linker Conjugates 1 5mg | Login | cIAP1 Ligand-Linker Conjugates 1 5mg | ||||||||||||||||
|
||||||||||||||||||
| (9Z,12E)-Tetradecadien-1-yl acetate 1mg | Login | (9Z,12E)-Tetradecadien-1-yl acetate 1mg | ||||||||||||||||
|
||||||||||||||||||
| (9Z,12E)-Tetradecadien-1-yl acetate 5mg | Login | (9Z,12E)-Tetradecadien-1-yl acetate 5mg | ||||||||||||||||
|
||||||||||||||||||
| (9Z,12E)-Tetradecadien-1-yl acetate 10mg | Login | (9Z,12E)-Tetradecadien-1-yl acetate 10mg | ||||||||||||||||
|
||||||||||||||||||
| SHP2 IN-1 1mg | Login | SHP2 IN-1 1mg | ||||||||||||||||
|
||||||||||||||||||
| SHP2 IN-1 5mg | Login | SHP2 IN-1 5mg | ||||||||||||||||
|
||||||||||||||||||
| SHP2 IN-1 10mg | Login | SHP2 IN-1 10mg | ||||||||||||||||
|
||||||||||||||||||
| SHP2 IN-1 50mg | Login | SHP2 IN-1 50mg | ||||||||||||||||
|
||||||||||||||||||


